Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > New Press Release - Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

View:

(0)
•••

Post by PressRelease on Mar 29, 2023 8:30am

New Press Release - Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

PMN310 demonstrated greater selectivity for target toxic oligomers over monomers compared to other amyloid-beta-directed antibodies. Greater selectivity of PMN310 for toxic oligomers indicates a potentially differentiated profile and supports further development TORONTO, Ontario and CAMBRIDGE...read article.

135

Comment

Comment by Gbathat on Mar 30, 2023 8:36pm

This data is phenomenal!!!!!!!! Congrats PMN! https://d1io3yog0oux5.cloudfront.net/_2a4309c96d878f12712eab5f8da7dca2/promisneurosciences/db/1004/8780/pdf/PMN310+Poster+Presentation+P0214+at+ADPD+2023.pdf

100

Comment

ProMIS Neurosciences Inc